Story perspectives

Quantum Computing Surge: 7 Stocks to Watch Now

9/5/2025

Summary

Quantum Leaders Invest

Quantum computing is rapidly advancing, with Microsoft, Google, and Amazon leading the shift.
Senior Stock Strategist Kevin Cook identifies seven stocks poised to excel in the quantum computing sector.
Teva Pharmaceutical reports strong sales for branded drugs like Austedo, Ajovy, and Uzedy amid generic competition.
Teva expects over $5 billion in revenue from branded products by 2030 and is enhancing its biosimilars pipeline.
Analysts consider quantum computing a key investment area, forecasting substantial innovation and growth.

Summary

Quantum Leaders Invest

Quantum computing is rapidly advancing, with Microsoft, Google, and Amazon leading the shift.
Senior Stock Strategist Kevin Cook identifies seven stocks poised to excel in the quantum computing sector.
Teva Pharmaceutical reports strong sales for branded drugs like Austedo, Ajovy, and Uzedy amid generic competition.
Teva expects over $5 billion in revenue from branded products by 2030 and is enhancing its biosimilars pipeline.
Analysts consider quantum computing a key investment area, forecasting substantial innovation and growth.

History

Historical Context

Richard Feynman proposed quantum computing in 1981, emphasizing its potential to surpass classical computers. By the 2010s, companies like IBM and D-Wave Systems were investing heavily in this technology. Today, major players such as Microsoft and Google are leading advancements, with quantum computing poised to revolutionize sectors like healthcare, as evidenced by Teva Pharmaceutical's projected $5 billion revenue from branded drugs.

1 of 3

Quantum Leaders Invest

Quantum computing is rapidly advancing, with Microsoft, Google, and Amazon leading the shift.
Senior Stock Strategist Kevin Cook identifies seven stocks poised to excel in the quantum computing sector.
Teva Pharmaceutical reports strong sales for branded drugs like Austedo, Ajovy, and Uzedy amid generic competition.
Teva expects over $5 billion in revenue from branded products by 2030 and is enhancing its biosimilars pipeline.
Analysts consider quantum computing a key investment area, forecasting substantial innovation and growth.

1 / 3